A Closer Look at Vascular Cell States in Marfan Syndrome

• March 25, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation

• by Andrea Surnit

• April 30, 2026

• 4 min

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

• by Kerri Miller

• April 17, 2026

• 6 min